Two years ago, the European Ombudsman ruled that the European Medicines Agency should open up access to Clinical Trial Data for anyone who applied from anywhere in the world.
Six months ago two US pharmaceutical companies AbbVie and InterMune took a legal action against EMA that has closed down access to all trial data for all drugs for all doctors and researchers anywhere in the world..
Most people have not heard of AbbVie. Until recently they were Abbott Laboratories, one of the biggest pharmaceutical companies in the world.
They make Humira, a monoclonal antibody used for Rheumatoid Arthritis, Crohn's Disease, Psoriasis and other conditions. It is the best selling drug in the world today, and projected to be the best selling drug of all time.
This is one of the most important legal actions in Healthcare ever. At a recent meeting in Bruxelles AbbVie made it clear that a main reason to keep clinical trial data confidential was to hide adverse event data, although there may be other issues like a Trade War with China..
You can read about this and see the whole video here
Essentially AbbVie are asking the Courts to grant their Corporation the privacy rights of an individual - a very powerful wealthy individual. If this legal action succeeds Adverse Event data will be hidden for ever.
Hence RxISK launched a petition calling on Richard Gonzalez, the CEO of AbbVie to drop his legal action against the EMA's policy of open access to clinical trial data. The petition is here
or in other languages from Spanish to Chinese on Rxisk here
This petition is as much for anyone who may be prescribed drugs as for those prescribing them - so we are hoping to spread word about it generally.
We are trying to get every country in the world to sign. We have 75 of the 180 countries in the world signed up but would love to have all.
We only have 3 weeks to get this done. All help would really be appreciated.
David
-- David Healy
Professor of Psychiatry
Hergest Unit
Bangor Wales LL57 2PW
United Kingdom
T 44-1248-384453
C 447771897792
E david.healy54@googlemail.com
No comments:
Post a Comment